FDA Approval Sought for “iglucose” Tracking Technology


By: Diabetes Health Staff

Florida-base PositiveID Corp. has filed a 510(k) application with the U.S Food and Drug Administration to market its “iglucose”TM diabetes management system.

The system transmits readings from a special glucometer to a diabetes management website where people with diabetes can track their glucose levels online. The data, which are secured, can be accessed by users’ family members and healthcare providers.

According to PositiveID, the system not only encourages greater self-management among people with diabetes, but also cuts down on the use of paper-based logbooks.

The 510(k) application is a request for the FDA to grant clearance to market the iglucose device in the United States.
More information on the technology is available here.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.